Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Molecular PathologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.Blood. 2019; 133 ([published correction appears in Blood. 2019 Sep 26;134(13):1112]): 1703-1714
- Diagnosis of T-cell lymphoid proliferations of the skin: putting all the pieces together.Mod Pathol. 2020; 33: 83-95
- WHO-EORTC classification for cutaneous lymphomas.Blood. 2005; 105: 3768-3785
- Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.J Clin Oncol. 2010; 28: 4730-4739
- Sézary syndrome.in: Swerdlow S.H. Campo E. Harris N.L. Classification of tumours of haematopoietic and lymphoid tissues, revised. 4th edition. IARC Press, Lyon (France)2017: 90
- T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.Br J Dermatol. 2005; 153: 565-573
- Views of dermatopathologists about clonality assays in the diagnosis of cutaneous T-cell and B-cell lymphoproliferative disorders.J Cutan Pathol. 2018; 45: 39-47
- Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): Part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.J Am Acad Dermatol. 2014; 70: e201-e216
- Diagnostic significance of TCR gene clonal rearrangement analysis in early mycosis fungoides.Chin J Cancer. 2011; 30: 264-272
- Diagnostic role of tests for T cell receptor (TCR) genes.J Clin Pathol. 2003; 56: 1-11
- Histopathologic-molecular correlation in early mycosis fungoides using T-cell receptor gamma gene rearrangement by polymerase chain reaction with laser capture microdissection.J Formos Med Assoc. 2007; 106: 265-272
- TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples.J Invest Dermatol. 2008; 128: 1030-1038
- An update on molecular biology of cutaneous T cell lymphoma.Front Oncol. 2020; 9: 1558
- T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides.J Am Acad Dermatol. 2015; 73: 228-236.e2
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).Blood. 2007; 110: 1713-1722
- Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.Sci Transl Med. 2013; 5: 214ra171
- Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group.Br J Dermatol. 2015; 173: 1015-1023
- The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality.Br J Dermatol. 2008; 159: 881-886
- High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.Sci Transl Med. 2018; 10: eaar5894
- Genomic landscape of cutaneous T cell lymphoma.Nat Genet. 2015; 47: 1011-1019
- Novel and highly recurrent chromosomal alterations in Sézary syndrome.Cancer Res. 2008; 68: 2689-2698
- Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.Br J Dermatol. 2002; 147: 464-475
- Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome.Blood. 2016; 127: 3387-3397
- Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.Nat Genet. 2015; 47: 1426-1434
- Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.Mol Genet Genomic Med. 2015; 3: 130-136
- Identification of gene mutations and fusion genes in patients with Sézary syndrome.J Invest Dermatol. 2016; 136: 1490-1499
- PLCG1 mutations in cutaneous T-cell lymphomas.Blood. 2014; 123: 2034-2043
- Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.Nat Genet. 2015; 47: 1056-1060
- Transcriptome sequencing in Sézary syndrome identifies Sézary cell and mycosis fungoides-associated lncRNAs and novel transcripts.Blood. 2012; 120: 3288-3297
- The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.Nat Genet. 2015; 47: 1465-1470
- Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides.Blood. 2015; 126: 508-519
- Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.Nat Commun. 2015; 6: 8470
- Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.Oncotarget. 2017; 8: 39627-39639
- Genetics of cutaneous T cell lymphoma: from bench to bedside.Curr Treat Options Oncol. 2016; 17: 33
- Mycosis fungoides and Sézary syndrome: an update.in: LeBoeuf N.R. Larocca C. Cutaneous malignancy. Elsevier, Philadelphia2019: p113
- TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides.Front Med (Lausanne). 2016; 3: 51
- Cellular interactions and inflammation in the pathogenesis of cutaneous T-cell lymphoma.Front Cell Dev Biol. 2020; 8: 851
- Molecular markers of early-stage mycosis fungoides.J Invest Dermatol. 2012; 132: 1698-1706
- Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis.Oncotarget. 2014; 5: 4418-4425
- TOX gene: a novel target for human cancer gene therapy.Am J Cancer Res. 2015; 5: 3516-3524
- New targeted treatments for cutaneous T-cell lymphomas.Indian J Dermatol. 2017; 62: 142-145
- Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis.Hum Pathol. 2000; 31: 1482-1490
- Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.Haematologica. 2015; 100: e450-e453
- Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.Br J Dermatol. 2020; 182: 147-155
- The use of transcriptional profiling to improve personalized diagnosis and management of cutaneous T-cell lymphoma (CTCL).Clin Cancer Res. 2015; 21: 2820-2829
- Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy.Blood. 2006; 107: 3189-3196
- Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis.Blood. 2013; 121: 1477-1478
- Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL).Blood. 2011; 118: 5891-5900
- Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.Blood. 2018; 131: 759-770
- Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.Blood. 2000; 95: 3653-3661
- Primary cutaneous CD30-positive lymphoproliferative disorders.in: Swerdlow S.H. Campo E. Harris N.L. Classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition. IARC Press, Lyon (France)2017: p395
- SATB1 defines a subtype of cutaneous CD30+ lymphoproliferative disorders associated with a T-helper 17 cytokine profile.J Invest Dermatol. 2018; 138: 1795-1804
- Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis.Am J Surg Pathol. 2013; 37: 173-181
- Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.Mod Pathol. 2011; 24: 596-605
- Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.J Invest Dermatol. 2010; 130: 1707-1718
- Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators.J Invest Dermatol. 2010; 130: 563-575
- A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.Blood. 2014; 124: 3768-3771
- ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.Haematologica. 2013; 98: 50-56
- ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course.J Cutan Pathol. 2015; 42: 870-877
- Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.Blood. 2012; 120: 2280-2289
- Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course.Blood Cancer J. 2014; 4: e253
- Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients.Blood. 2009; 102: 2213-2219
- Primary cutaneous peripheral T-cell lymphoma, rare subtypes.in: Swerdlow S.H. Campo E. Harris N.L. Classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition. IARC Press, Lyon (France)2017: p397-p402
- Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.Am J Surg Pathol. 2009; 33: 81-90
- Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.J Cutan Pathol. 2016; 43: 1121-1130
- Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.Hum Pathol. 1998; 29: 397-403
- T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome.Am J Surg Pathol. 1991; 15: 17-27
- Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome.Br J Dermatol. 2015; 172: 793-797
- Subcutaneous lymphoma and related conditions.Dermatol Ther. 2010; 23: 350-355
- Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.Nat Genet. 2018; 50: 1650-1657
- Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases.Blood. 2008; 111: 838-845
- Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas.Am J Surg Pathol. 2012; 36: 1656-1665
- Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas.Nat Commun. 2020; 11: 1806
- Primary cutaneous T-cell lymphomas showing gamma-delta (γδ) phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous γδ T-cell lymphomas.Am J Surg Pathol. 2017; 41: 204-215
- Aggressive epidermotropic cutaneous CD30(+) lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop.Histopathology. 2015; 67: 425-441
- Primary cutaneous cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway.Blood. 2021; 138: 2435-2440
- Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.Lancet Oncol. 2018; 19: 1192-1204
- Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.Lancet. 2017; 390: 555-566
- Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.Genes Chromosomes Cancer. 2018; 57: 653-664
- Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.Blood. 2018; 131: 888-898
- Pembrolizumab in relapsed and refractory mycosis fungoides and Sézary syndrome: a multicenter phase II study.J Clin Oncol. 2020; 38: 20-28
Article info
Publication history
Published online: September 28, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
